Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
39.38
+1.27 (3.33%)
At close: Dec 5, 2025, 4:00 PM EST
39.98
+0.60 (1.52%)
After-hours: Dec 5, 2025, 6:51 PM EST
Zenas BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 2,114 | 342 | - | - |
| Enterprise Value | 1,824 | -44 | - | - |
| Last Close Price | 39.38 | 8.19 | - | - |
| PS Ratio | 110.11 | 68.45 | - | - |
| PB Ratio | 8.46 | 1.10 | - | - |
| P/TBV Ratio | 10.76 | 1.10 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.87 | 0.03 |
| Asset Turnover | 0.04 | 0.02 | 0.70 | - |
| Quick Ratio | 5.57 | 6.12 | 2.44 | 2.59 |
| Current Ratio | 5.66 | 6.21 | 2.57 | 2.64 |
| Return on Equity (ROE) | -68.33% | -93.22% | -102.89% | - |
| Return on Assets (ROA) | -33.72% | -46.76% | -23.77% | - |
| Return on Capital (ROIC) | -43.91% | -57.07% | -35.79% | - |
| Return on Capital Employed (ROCE) | -72.60% | -52.40% | -60.40% | -154.70% |
| Earnings Yield | -8.98% | -45.87% | - | - |
| FCF Yield | -7.50% | -35.00% | - | - |
| Buyback Yield / Dilution | -1252.33% | -762.01% | -2.61% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.